Marcin Hachula
Katowice, SL 40752, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The Crucial Question About Contrast-Induced Nephropathy (CIN): Should It Affect Clinical Practice?
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 03, 2024
Influence of Dulaglutide on Serum Biomarkers of Atherosclerotic Plaque Instability: An Interventional Analysis of Cytokine Profiles in Diabetic Subjects-A Pilot Study.
Journal: Medicina (Kaunas, Lithuania)
Published: May 07, 2024
Effect of GLP-1RA Treatment on Adhesion Molecules and Monocyte Chemoattractant Protein-1 in Diabetic Patients with Atherosclerosis.
Journal: Life (Basel, Switzerland)
Published: April 12, 2024
Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process.
Journal: International journal of molecular sciences
Published: December 21, 2023
Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes-Interventional Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 29, 2023
The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods.
Journal: Molecules (Basel, Switzerland)
Published: June 26, 2023
Initial clinical, laboratory and radiological features of SARS-CoV-2-infected patients and their impact on the course of the disease.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: March 30, 2023
The Impact of Various Methods of Obesity Treatment on the Quality of Life and Mental Health-A Narrative Review.
Journal: International journal of environmental research and public health
Published: December 23, 2022
Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.
Journal: Medicina (Kaunas, Lithuania)
Published: June 23, 2022
Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 07, 2022
Plasma Concentrations of New Biochemical Markers of Atherosclerosis in Patients with Dyslipidemia-A Pilot Study.
Journal: Medicina (Kaunas, Lithuania)
Published: April 11, 2022
Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia.
Journal: Journal of clinical medicine
Published: March 22, 2022
Last Updated: 09/26/2026